In recent years, the incidence of non-viral hepatocellular carcinoma (HCC) has increased
dramatically, which is probably related to the increased prevalence of metabolic syndrome …

In recent years, the prevalence of metabolic-associated fatty liver disease (MAFLD) has
reached pandemic proportions as a leading cause of liver fibrosis worldwide. However, the …

Non-alcoholic fatty liver disease (NAFLD) has become a major chronic disease in
contemporary society, affected by N6-methyladenosine (m6A) RNA methylation, one of the …

Background: This observational cross-sectional study was designed to explore the effects of
a low-carbohydrate diet (LCD) and a low-fat diet (LFD) on metabolic-dysfunction-associated …

The moonlighting protein c-Myc is a master regulator of multiple biological processes
including cell proliferation, differentiation, angiogenesis, apoptosis and metabolism. It is …

MAFLD stands for metabolic-related fatty liver disease, which is a prevalent liver disease
affecting one-third of adults worldwide, and is strongly associated with obesity …

Metabolic associated fatty liver disease (MAFLD) is a significant risk factor for the
development of hepatocellular carcinoma (HCC). Hepatic stellate cells (HSCs), as key …

Monitoring of trace c‐Myc protein as the biomarker of ubiquitous cancers is critical in
achieving predictive medical diagnostics. However, qualitative and quantitative detection of …

In recent years, there has been a significant increase in the incidence of metabolic-
associated fatty liver disease (MAFLD), which has been attributed to the increasing …

Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma
secondary to metabolic-dysfunction associated steatotic liver disease - PMC Back to Top Skip …